http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105695404-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-599 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2302 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2301 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2321 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0646 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 |
filingDate | 2016-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105695404-B |
titleOfInvention | Amplification activation method of CIK lymphocytes |
abstract | The invention discloses a method for activating CIK cells by using a host cell transfected with functional proteins and combining amplification of multiple proteins. Compared with the existing method, the method has the advantages that the purity of the expanded and activated CIK cells is higher, the expansion efficiency is higher, and the ability of killing tumors and TAMs in the tumor microenvironment is stronger. The present invention has broad prospects in controlling and alleviating the progression of some diseases, such as cancer, infectious diseases, diabetes, or organ transplantation and hepatitis B. |
priorityDate | 2016-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 189.